E-LIB Suche - Ergebnisse für: Idorn, Thomas

1

#2496 Effect of semaglutide on kidney outcomes in people wi..:

Colhoun, Helen M ; Lingvay, Ildiko ; Brown, Paul M...
Nephrology Dialysis Transplantation. 39 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

2

Long-term kidney outcomes of semaglutide in obesity and car..:

Colhoun, Helen M. ; Lingvay, Ildiko ; Brown, Paul M....
Nature Medicine. 30 (2024) 7 - p. 2058-2066 , 2024

Link: https://doi.org/10.1038/..

3

Effects of semaglutide with and without concomitant SGLT2 i..:

Mann, Johannes F. E. ; Rossing, Peter ; Bakris, George...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

4

Glucose metabolism, gut-brain hormones, and acromegaly trea..:

Jørgensen, Nanna Thurmann ; Erichsen, Trine Møller ; Jørgensen, Morten Buus...
Pituitary. 26 (2023) 1 - p. 152-163 , 2023

Link: https://doi.org/10.1007/..

5

Obesity-Related Kidney Disease: Current Understanding and F..:

Kreiner, Frederik F. ; Schytz, Philip Andreas ; Heerspink, Hiddo J. L...
Biomedicines. 11 (2023) 9 - p. 2498 , 2023

Link: https://doi.org/10.3390/..

6

The rationale, design and baseline data of FLOW, a kidney o..:

Rossing, Peter ; Baeres, Florian M M ; Bakris, George...
Nephrology Dialysis Transplantation. 38 (2023) 9 - p. 2041-2051 , 2023

Link: https://doi.org/10.1093/..

7

The potential of GLP-1 receptor agonists in type 2 diabetes..:

von Scholten, Bernt Johan ; Kreiner, Frederik Flindt ; Rasmussen, Søren..
Therapeutic Advances in Endocrinology and Metabolism. 13 (2022) - p. 204201882211124 , 2022

Link: https://doi.org/10.1177/..

8

Effect of the Glucagon-Like Peptide-1 Receptor Agonists Sem..:

Shaman, Ahmed M. ; Bain, Stephen C. ; Bakris, George L....
Circulation. 145 (2022) 8 - p. 575-585 , 2022

Link: https://doi.org/10.1161/..

9

FC 123: Baseline Characteristics of the Flow Trial Populati..:

Perkovic, Vlado ; Baeres, Florian ; Bakris, George...
Nephrology Dialysis Transplantation. 37 (2022) Supplement_3 - p. , 2022

Link: https://doi.org/10.1093/..

10

Potential kidney protection with liraglutide and semaglutid..:

Mann, Johannes F. E. ; Buse, John B. ; Idorn, Thomas...
Diabetes, Obesity and Metabolism. 23 (2021) 9 - p. 2058-2066 , 2021

Link: https://doi.org/10.1111/..

11

Cardiovascular and renal outcomes by baseline albuminuria s..:

Mosenzon, Ofri ; Bain, Stephen C. ; Heerspink, Hiddo J. L....
Diabetes, Obesity and Metabolism. 22 (2020) 11 - p. 2077-2088 , 2020

Link: https://doi.org/10.1111/..

12

MO051EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCO..:

Bain, Stephen C ; Wolthers, Benjamin ; Rasmussen, Søren...
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..

13

TO002REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE..:

Bain, Stephen C ; Wolthers, Benjamin ; Rasmussen, Søren...
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..

14

OR23-06 Is the Improved Glucose Homeostasis in Patients wit..:

Rasmussen, Ulla Feldt ; Holst, Jens J ; Rasmussen, Bo F...
Journal of the Endocrine Society. 4 (2020) Supplement_1 - p. , 2020

Link: https://doi.org/10.1210/..

15

Gastrointestinal motility in patients with end‐stage renal ..:

Broberg, Bo ; Madsen, Jan L. ; Fuglsang, Stefan...
Neurogastroenterology & Motility. 31 (2019) 4 - p. , 2019

Link: https://doi.org/10.1111/..